Advertisement




Mac Miller Does Fake Drug Ad For Funny Or Die

(Radio.com) Mac Miller stars in a new Funny or Die commercial about getting sad right quick. In the fake ad, Miller reps the pharmaceutical solution DreadLexa aka The First Depressant For Rappers.

"As an artist, depression and anxiety are part of my creative process, so when I found myself suffering from chronic happiness and contentment, I knew I had to do something," he says in the beginning. He explains taking Dreadlexa allowed him to tap into his demons once again.

A voiceover breaks down how the drug works. "Dreadlexa is the first prescription depressant created for musicians, designed to drag you back into that dark creative space you fear and need to create music people respect."

The voiceover adds, "Dreadlexa works best if taken with alcohol after Googling yourself." But rappers should be careful. If they take too much Dreadlexa they're likely to produce too many banger tracks, which can cause a rise in self-esteem. Check it out here.


Advertisement




Related Stories
  • Mac Miller And Ty Dolla Sign Release Epic 'Cinderella' Video
  • Ariana Grande Talks Relationship With Mac Miller
  • Mac Miller Does Fake Drug Ad For Funny Or Die
  • Mac Miller Releases Video for 'Stay'
  • Mac Miller And Ariana Grande Duet 'My Favorite Part' In New Video
  • Ariana Grande and Mac Miller Take Their Mothers On A Date
  • Mac Miller Opens Up About 'Love' On His New Album
  • Mac Miller and Ariana Grande Release 'My Favorite Part'
  • Ariana Grande And Mac Miller Show Off New Tattoos
  • Paparazzi Catch Ariana Grande And Mac Miller Kissing
  • More Stories for Mac Miller
  • Mac Miller Music
  • News Reports
    Day in Rock: Def Leppard Celebrate Pyromania's 40th Anniversary- Billy Idol Shares Previously Unreleased Song From Rebel Yell Sessions- more

    Watch Motley Crue's 'Dogs Of War' Video- blink-182 Tour- Richie Sambora Returns With 'I Pray', The First Of Four New Songs- more


    Contact Us - Privacy

    Copyright 2023 Iconoclast Entertainment Group All rights reserved.